Lexicon Pharmaceuticals (LXRX) FCF Margin Growth (3y) (2013 - 2024)
Lexicon Pharmaceuticals (LXRX) FCF Margin Growth (3y) (2013 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Lexicon Pharmaceuticals |
804.48 Mn |
633.82 Mn |
20.99 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-812,884.00 |
| Jun 30, 2024 |
679,277.00 |
| Mar 31, 2024 |
8.83 Mn |
| Dec 31, 2023 |
-674,327.00 |
| Jun 30, 2023 |
17.31 Mn |
| Dec 31, 2021 |
820,526.00 |
| Jun 30, 2021 |
-937,436.00 |
| Mar 31, 2021 |
-9.31 Mn |
| Dec 31, 2020 |
24,357.00 |
| Jun 30, 2020 |
-18.49 Mn |
| Mar 31, 2020 |
20,079.00 |
| Dec 31, 2019 |
-6,682.00 |
| Jun 30, 2019 |
-3,944.00 |
| Mar 31, 2019 |
-70,278.00 |
| Dec 31, 2018 |
-36,786.00 |
| Sep 30, 2018 |
421,670.00 |
| Jun 30, 2018 |
830,035.00 |
| Mar 31, 2018 |
112,700.00 |
| Dec 31, 2017 |
-7,835.00 |
| Sep 30, 2017 |
493,601.00 |
